Search Results - "CHARMAN, C"

Refine Results
  1. 1
  2. 2

    Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods by Charman, C.R., Venn, A.J., Ravenscroft, J.C., Williams, H.C.

    Published in British journal of dermatology (1951) (01-12-2013)
    “…Summary Background The Patient‐Oriented Eczema Measure (POEM) is a validated, patient‐derived assessment measure for monitoring atopic eczema severity,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and Competition by Aggarwal, Ajay, Lewis, Daniel, Charman, Susan C., Mason, Malcolm, Clarke, Noel, Sullivan, Richard, van der Meulen, Jan

    Published in European urology (01-06-2018)
    “…Many countries have introduced policies that enable patients to select a health care provider of their choice with the aim of improving the quality of care…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Topical corticosteroid phobia in patients with atopic eczema by Charman, C.R., Morris, A.D., Williams, H.C.

    Published in British journal of dermatology (1951) (01-05-2000)
    “…Topical corticosteroids are widely prescribed by dermatologists caring for patients with atopic eczema. Patients’ fears about using topical corticosteroids may…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study by Sujenthiran, Arunan, Nossiter, Julie, Parry, Matthew, Charman, Susan C., Cathcart, Paul J., van der Meulen, Jan, Clarke, Noel W., Payne, Heather, Aggarwal, Ajay

    Published in Radiotherapy and oncology (01-08-2018)
    “…In the post-prostatectomy setting the value of Intensity-modulated (IMRT) relative to 3D-conformal radiotherapy (3D-CRT) in reducing toxicity remains unclear…”
    Get full text
    Journal Article
  9. 9

    Measuring Atopic Dermatitis Severity in Randomized Controlled Clinical Trials: What Exactly Are We Measuring? by Charman, Carolyn, Chambers, Colette, Williams, Hywel

    Published in Journal of investigative dermatology (01-06-2003)
    “…Well-designed clinical trials are a fundamental aspect of evidence-based medicine. Such trials are dependent on the use of valid, reliable, and relevant…”
    Get full text
    Journal Article
  10. 10

    Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review by Stanford, Gemma E., Jones, Mandy, Charman, Susan C., Bilton, Diana, Usmani, Omar S., Davies, Jane C., Simmonds, Nicholas J.

    “…Background: Airway clearance techniques (ACTs) are integral to cystic fibrosis (CF) management. However, there is no consensus as to which outcome measures…”
    Get full text
    Book Review Journal Article
  11. 11

    Reactivity and Stability of a Ring-Expanded N-Heterocyclic Carbene Copper(I) Boryl Imidinate by Charman, Rex S. C., Horsley Downie, Thomas M., Jerome, Thomas H., Mahon, Mary F., Liptrot, David J.

    Published in Inorganics (01-09-2022)
    “…Frustrated Lewis pairs (FLPs) have evolved from a revolutionary concept to widely applied catalysts. We recently reported the ring-expanded N-heterocyclic…”
    Get full text
    Journal Article
  12. 12

    Performance status score: do patients and their oncologists agree? by BLAGDEN, S. P, CHARMAN, S. C, SHARPLES, L. D, MAGEE, L. R. A, GILLIGAN, D

    Published in British journal of cancer (15-09-2003)
    “…Oncologists traditionally assess their patients' ECOG performance status (PS), and few studies have evaluated the accuracy of these assessments. In this study,…”
    Get full text
    Journal Article
  13. 13

    Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer by Win, T, Jackson, A, Groves, A M, Sharples, L D, Charman, S C, Laroche, C M

    Published in Thorax (01-01-2006)
    “…Background: The relationship between the shuttle walk test and peak oxygen consumption in patients with lung cancer has not previously been reported. A study…”
    Get full text
    Journal Article
  14. 14
  15. 15

    CT colonography: investigation of the optimum reader paradigm by using computer-aided detection software by Taylor, Stuart A, Charman, Susan C, Lefere, Philippe, McFarland, Elizabeth G, Paulson, Erik K, Yee, Judy, Aslam, Rizwan, Barlow, John M, Gupta, Arun, Kim, David H, Miller, Chad M, Halligan, Steve

    Published in Radiology (01-02-2008)
    “…To prospectively compare the diagnostic performance and time efficiency of both second and concurrent computer-aided detection (CAD) reading paradigms for…”
    Get more information
    Journal Article
  16. 16

    The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading by Emerson, R.M., Charman, C.R., Williams, H.C.

    Published in British journal of dermatology (1951) (01-02-2000)
    “…A method for assessing disease severity of atopic dermatitis (AD) in children has been developed for population‐based research. Based on an index first…”
    Get full text
    Journal Article
  17. 17

    Vacuum-assisted closure as a treatment modality for infections after cardiac surgery by Luckraz, Heyman, Murphy, Fiona, Bryant, Steve, Charman, Susan C., Ritchie, Andrew J.

    “…Objective: Wound infections after cardiac surgery carry high morbidity and mortality. A plethora of management strategies have been used to treat such…”
    Get full text
    Journal Article
  18. 18

    Who are the 10%? - Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies by Desai, Maya, Hine, Chris, Whitehouse, Joanna L., Brownlee, Keith, Charman, Susan C., Nagakumar, Prasad

    Published in Respiratory medicine (01-08-2022)
    “…The availability of mutation-specific cystic fibrosis modulator therapies has the potential to improve the lives of children and adults with cystic fibrosis…”
    Get full text
    Journal Article
  19. 19

    Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data by Frost, Freddy J, Nazareth, Dilip S, Charman, Susan C, Winstanley, Craig, Walshaw, Martin J

    Published in Annals of the American Thoracic Society (01-11-2019)
    “…Ivacaftor can greatly improve clinical outcomes in people with cystic fibrosis (CF) and has been shown to have antibacterial properties, yet the long-term…”
    Get full text
    Journal Article
  20. 20

    Relationship between patients' and clinicians' assessments of health status before and after knee arthroplasty by Bream, Elizabeth, Charman, Susan C, Clift, Ben, Murray, David, Black, Nick

    Published in Quality & safety in health care (01-12-2010)
    “…The use of patient reported outcome measures (PROMs) for four elective operations is mandatory in the English NHS from April 2009. In view of some scepticism…”
    Get more information
    Journal Article